Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study

BACKGROUND: Even in the immuno-oncology era, transcatheter arterial chemoembolisation (TACE) is the most effective way to treat intermediate stage hepatocellular carcinoma (HCC). Postembolisation syndrome (PES) is the most common side effect from TACE and there is still no standard prevention guidel...

Descripción completa

Detalles Bibliográficos
Autores principales: Sainamthip, Panot, Kongphanich, Chutcharn, Prasongsook, Naiyarat, Chirapongsathorn, Sakkarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567509/
https://www.ncbi.nlm.nih.gov/pubmed/34786388
http://dx.doi.org/10.12998/wjcc.v9.i30.9059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567509/
https://www.ncbi.nlm.nih.gov/pubmed/34786388
http://dx.doi.org/10.12998/wjcc.v9.i30.9059

Ejemplares similares